Intranasal drug delivery: opportunities and toxicologic challenges during drug development.
Keller LA, Merkel O, Popp A. · 2022
Read Intranasal drug delivery: opportunities and toxicologic challenges during drug development. by Keller LA, Merkel O, Popp A. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7829061.txt.
Description
Keller and co-authors review drug delivery through the nose and its safety hurdles. Interest in nasal delivery rose over the past 10 years. The nose offers a non-invasive route into the body. Onset is fast and side effects can drop.
Nasal sprays can act locally or body-wide. They hold special promise for brain disorders. Standard routes often fail to supply the brain well. The authors set out nose anatomy and function first. Approved nasal drugs are listed next. Safety testing of nasal products gets deep coverage. Formula design issues close the review. Both gains and toxic risks must guide development.
Catalog record
| CREATOR | Keller LA, Merkel O, Popp A. |
|---|---|
| YEAR | 2022 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 127 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |